197 related articles for article (PubMed ID: 10454092)
1. Matrix metalloproteinase-2 and -9 are activated in joint diseases.
Clegg PD; Carter SD
Equine Vet J; 1999 Jul; 31(4):324-30. PubMed ID: 10454092
[TBL] [Abstract][Full Text] [Related]
2. Characterisation of equine matrix metalloproteinase 2 and 9; and identification of the cellular sources of these enzymes in joints.
Clegg PD; Burke RM; Coughlan AR; Riggs CM; Carter SD
Equine Vet J; 1997 Sep; 29(5):335-42. PubMed ID: 9306058
[TBL] [Abstract][Full Text] [Related]
3. Recombinant equine interleukin-1beta induces putative mediators of articular cartilage degradation in equine chondrocytes.
Tung JT; Fenton JI; Arnold C; Alexander L; Yuzbasiyan-Gurkan V; Venta PJ; Peters TL; Orth MW; Richardson DW; Caron JP
Can J Vet Res; 2002 Jan; 66(1):19-25. PubMed ID: 11858644
[TBL] [Abstract][Full Text] [Related]
4. Matrix metalloproteinases 2 and 9 in equine synovial fluids.
Clegg PD; Coughlan AR; Riggs CM; Carter SD
Equine Vet J; 1997 Sep; 29(5):343-8. PubMed ID: 9306059
[TBL] [Abstract][Full Text] [Related]
5. Synovial fluid gelatinase concentrations and matrix metalloproteinase and cytokine expression in naturally occurring joint disease in horses.
Trumble TN; Trotter GW; Oxford JR; McIlwraith CW; Cammarata S; Goodnight JL; Billinghurst RC; Frisbie DD
Am J Vet Res; 2001 Sep; 62(9):1467-77. PubMed ID: 11560279
[TBL] [Abstract][Full Text] [Related]
6. Mast cell activation and its relation to proinflammatory cytokine production in the rheumatoid lesion.
Woolley DE; Tetlow LC
Arthritis Res; 2000; 2(1):65-74. PubMed ID: 11219391
[TBL] [Abstract][Full Text] [Related]
7. Determination of MMP-2 and -9 activities in synovial fluid of horses with osteoarthritic and arthritic joint diseases using gelatin zymography and immunocapture activity assays.
Fietz S; Einspanier R; Hoppner S; Hertsch B; Bondzio A
Equine Vet J; 2008 May; 40(3):266-71. PubMed ID: 18089467
[TBL] [Abstract][Full Text] [Related]
8. The effects of 1 alpha,25-dihydroxyvitamin D(3) on matrix metalloproteinase and prostaglandin E(2) production by cells of the rheumatoid lesion.
Tetlow LC; Woolley DE
Arthritis Res; 1999; 1(1):63-70. PubMed ID: 11056661
[TBL] [Abstract][Full Text] [Related]
9. Equine TIMP-1 and TIMP-2: identification, activity and cellular sources.
Clegg PD; Coughlan AR; Carter SD
Equine Vet J; 1998 Sep; 30(5):416-23. PubMed ID: 9758100
[TBL] [Abstract][Full Text] [Related]
10. Matrix metalloproteinase and proinflammatory cytokine production by chondrocytes of human osteoarthritic cartilage: associations with degenerative changes.
Tetlow LC; Adlam DJ; Woolley DE
Arthritis Rheum; 2001 Mar; 44(3):585-94. PubMed ID: 11263773
[TBL] [Abstract][Full Text] [Related]
11. The effect of drugs commonly used in the treatment of equine articular disorders on the activity of equine matrix metalloproteinase-2 and 9.
Clegg PD; Jones MD; Carter SD
J Vet Pharmacol Ther; 1998 Oct; 21(5):406-13. PubMed ID: 9811443
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-1 stimulation of equine articular cells.
May SA; Hooke RE; Lees P
Res Vet Sci; 1992 May; 52(3):342-8. PubMed ID: 1620968
[TBL] [Abstract][Full Text] [Related]
13. Concentration-dependent effects of tiludronate on equine articular cartilage explants incubated with and without interleukin-1β.
Duesterdieck-Zellmer KF; Driscoll N; Ott JF
Am J Vet Res; 2012 Oct; 73(10):1530-9. PubMed ID: 23013178
[TBL] [Abstract][Full Text] [Related]
14. Batimastat (BB-94) inhibits matrix metalloproteinases of equine laminitis.
Pollitt CC; Pass MA; Pollitt S
Equine Vet J Suppl; 1998 Sep; (26):119-24. PubMed ID: 9932102
[TBL] [Abstract][Full Text] [Related]
15. Effects of glucosamine and chondroitin sulfate on mediators of osteoarthritis in cultured equine chondrocytes stimulated by use of recombinant equine interleukin-1beta.
Neil KM; Orth MW; Coussens PM; Chan PS; Caron JP
Am J Vet Res; 2005 Nov; 66(11):1861-9. PubMed ID: 16334941
[TBL] [Abstract][Full Text] [Related]
16. Pro-MMP-9 is a specific macrophage product and is activated by osteoarthritic chondrocytes via MMP-3 or a MT1-MMP/MMP-13 cascade.
Dreier R; Grässel S; Fuchs S; Schaumburger J; Bruckner P
Exp Cell Res; 2004 Jul; 297(2):303-12. PubMed ID: 15212936
[TBL] [Abstract][Full Text] [Related]
17. Activation of matrix metalloproteinases 2, 9, and 13 by activated protein C in human osteoarthritic cartilage chondrocytes.
Jackson MT; Moradi B; Smith MM; Jackson CJ; Little CB
Arthritis Rheumatol; 2014 Jun; 66(6):1525-36. PubMed ID: 24574263
[TBL] [Abstract][Full Text] [Related]
18. Hemoglobin stimulates the expression of matrix metalloproteinases, MMP-2 and MMP-9 by synovial cells: a possible cause of joint damage after intra-articular hemorrhage.
Tajima T; Yoshida E; Yamashita A; Ohmura S; Tomitaka Y; Sugiki M; Asada Y; Maruyama M
J Orthop Res; 2005 Jul; 23(4):891-8. PubMed ID: 16023005
[TBL] [Abstract][Full Text] [Related]
19. Matrix metalloproteinase 10 promotion of collagenolysis via procollagenase activation: implications for cartilage degradation in arthritis.
Barksby HE; Milner JM; Patterson AM; Peake NJ; Hui W; Robson T; Lakey R; Middleton J; Cawston TE; Richards CD; Rowan AD
Arthritis Rheum; 2006 Oct; 54(10):3244-53. PubMed ID: 17009259
[TBL] [Abstract][Full Text] [Related]
20. Expression of membrane-type 1 matrix metalloproteinase and activation of progelatinase A in human osteoarthritic cartilage.
Imai K; Ohta S; Matsumoto T; Fujimoto N; Sato H; Seiki M; Okada Y
Am J Pathol; 1997 Jul; 151(1):245-56. PubMed ID: 9212749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
